Skip to content

Dine Brands Global DIN Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount

Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount at other companies

AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
$1.5M-27.0%
CarGurus, Inc. logo
CarGurus, Inc.CARG
$980.25K
ESN
Essent GroupESNT
$79K-61.8%
Vertex, Inc. logo
Vertex, Inc.VERX
$1.13M-8.4%
Bicara Therapeutics logo
Bicara TherapeuticsBCAX
$844.25K
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
$330.75K-25.0%

Other financials

Income statement

See full
Revenue$225.2M+4.8%
Gross profit$142.9M+7.0%
Net income$7.4M-9.8%
EPS (diluted)$0.57+7.5%

Balance sheet

See full
Cash & equivalents$172.9M-31.0%
Total debt$1.6B-0.2%
Total equity-$290.0M-34.4%
Total assets$1.7B-4.4%

Cash flow

See full
Operating cash flow$7.5M-53.4%
CapEx$12.1M+267%
Free cash flow-$4.6M-136%

Valuation

See full
Market cap$431.42M+1.5%
Enterprise value$1.87B+4.5%
P/E11.7×+6.4×
P/S0.5×0.0×

Profitability

See full
Gross margin63.5%+4.3pp
Net margin4%-7.4pp
FCF margin10.2%-3.8pp

Returns & leverage

See full
Return on equity32.8%
Debt / equity5.2×
Current ratio0.9×0.0×

Where this comes from

Reported directly by Dine Brands Global in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxReconciliationTaxCreditsResearch.

The official record: Dine Brands Global’s 10-K, filed February 25, 2026, on SEC EDGAR. View the filing →

Ask your AI about Dine Brands Global's effective income tax rate reconciliation, tax credit, research, amount.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Dine Brands Global's effective income tax rate reconciliation, tax credit, research, amount?
Dine Brands Global (DIN) reported effective income tax rate reconciliation, tax credit, research, amount of $150K in Q4 2025.
What does effective income tax rate reconciliation, tax credit, research, amount mean?
This metric represents the absolute dollar value of tax credits claimed by the company for qualified research and development activities. It reflects the company's investment in innovation and the resulting reduction in its total income tax expense. Investors track this to evaluate the scale of R&D initiatives and their direct impact on bottom-line profitability.